Skip to content
UniqueBaseEN
For AI ↗
Companies

Promise Bio

Visit website ↗
Snapshot

As of Oct 20, 2026, UniqueBase lists 1 funding record for Promise Bio; the latest is $8.3M (Seed) on Dec 26, 2024.

Funding records
1
Latest round
$8.3M · Seed
Total raised (reported)
—
Rows with a source link
0 of 1

Overview

Promise Bio is a company headquartered in Rehovot, Israel.

Summary generated from the structured facts on this page.

Funding · 1

Funding

Amounts as reported; USD estimates shown only when they match

Listed 1 funding record. Latest funding: $8.3M (Seed), Dec 26, 2024.

Annual trendUnit: USD
2024$8.3MDec 26, 2024: $8.3M · Seed
DateAmountInvestorsSources
Dec 26, 2024$8.3M · SeedAstraZeneca, Awz Ventures, Pfizer No source link

Select ▸ on a row to see its source brief and links.

Valuation · 1

Valuation

Amounts as reported; USD estimates shown only when they match

Listed 1 valuation record.

Annual trendUnit: USD

No chartable valuation estimates yet.

1 listed record lack a clear date or positive USD estimate for the chart.

DateAmountInvestorsSources
Dec 26, 2024— · SeedAstraZeneca, Awz Ventures, Pfizer No source link

Select ▸ on a row to see its source brief and links.

Revenue

Revenue

Amounts as reported; USD estimates shown only when they match

No revenue records are listed yet.

No revenue rows to list.

Team, products & investors

Explore

Sources · 0

Sources & provenance

English text is maintained separately from the original record. Consult the original source before citing a fact.

No source links are available for this profile.